22 - Clinical Trials That May Change Your Practice

Thursday, October 20, 2022

10:30 AM – 11:45 AM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Thomas Holland, MD

Associate Professor, Department of Medicine, Division of Infectious Diseases
Duke University Medical Center
Durham, North Carolina, United States

Disclosure(s): Aridis: Advisor/Consultant (); Basilea Pharmaceutica: Advisor/Consultant (); Karius: Advisor/Consultant (); Lysovant: Advisor/Consultant ()
Nwora Lance Okeke, MD, MPH

Assistant Professor
Medicine
Duke University
Durham, NC, United States

Disclosure(s): Gilead Biosciences: Honoraria (Terminated)

Faculty(s)

Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID

Clinical Associate Professor
University of South Carolina College of Pharmacy
Columbia, SC, United States

Disclosure(s): bioMérieux: Speaker's Bureau (Terminated); Entasis Therapeutics: Advisor/Consultant (Terminated); Gilead Sciences Inc.: Advisor/Consultant (Terminated); Merck & Co. Inc: Advisor/Consultant (Terminated); Shionogi, Inc.: Advisor/Consultant (Terminated); Spero Therapeutics: Speaker (Terminated); Vaxart Inc: Stocks/Bonds (Ongoing)

Slides
Anne Luetkemeyer, MD

Professor of Medicine
Zuckerberg San Francisco General, University of California, San Francisco, CA, USA
San Francisco, California, United States

Disclosure(s): Gilead Biosciences: Grant/Research Support (Terminated); Shionogi: Grant/Research Support (Ongoing)

Slides
Kayla Stover Hielscher, PharmD

Professor of Pharmacy Practice
University of Mississippi School of Pharmacy
Madison, MS, United States

Disclosure(s): Cidara Therapeutics Inc.: Advisor/Consultant (Terminated)

Slides

Disclosure(s):

Thomas L. Holland, MD: Aridis: Advisor/Consultant (); Basilea Pharmaceutica: Advisor/Consultant (); Karius: Advisor/Consultant (); Lysovant: Advisor/Consultant ()

Nwora Lance Okeke, MD, MPH: Gilead Biosciences: Honoraria (Terminated)

Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID: bioMérieux: Speaker's Bureau (Terminated); Entasis Therapeutics: Advisor/Consultant (Terminated); Gilead Sciences Inc.: Advisor/Consultant (Terminated); Merck & Co. Inc: Advisor/Consultant (Terminated); Shionogi, Inc.: Advisor/Consultant (Terminated); Spero Therapeutics: Speaker (Terminated); Vaxart Inc: Stocks/Bonds (Ongoing)

Anne F. Luetkemeyer, MD: Gilead Biosciences: Grant/Research Support (Terminated); Shionogi: Grant/Research Support (Ongoing)

Kayla R. Stover Hielscher, PharmD: Cidara Therapeutics Inc.: Advisor/Consultant (Terminated)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

critically appraise recent evidence in bacterial, viral and fungal trials;
apply the results of recent bacterial clinical trials to their practice;
apply the results of recent fungal and viral studies to their practice

Presentations:

10:30 AM – 10:55 AM US ET

Clinical Trials in Bacterial Diseases That May Change Your Practice
Speaker: Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID – University of South Carolina College of Pharmacy
10:55 AM – 11:20 AM US ET

Clinical Trials in Viral Diseases That May Change Your Practice
Speaker: Anne F. Luetkemeyer, MD – Zuckerberg San Francisco General, University of California, San Francisco, CA, USA
11:20 AM – 11:45 AM US ET

Clinical Trials in Fungal Diseases That May Change Your Practice
Speaker: Kayla R. Stover Hielscher, PharmD – University of Mississippi School of Pharmacy